英国药典Appendix XVI C翻译

合集下载

部分常用药物中英文名称对照表

Artemisinin(Arteannuine)
氟轻松（肤轻松）
Fluocinolone Acetonide
蒿甲醚
Artemether
克霉唑（氯三苯甲咪唑）
Clotrimazole(Lotrimin)
伯氨喹（伯喹）
Primaquine
咪康唑（达克宁）
Miconazole
乙胺嘧啶（息疟定）
Pyrimethamine(Daraprim)
头孢氨苄（先锋霉素IV）
Cefalexin(Cephalexin,keflex)
阿司匹林（乙酰水杨酸）
Aspirin(Acetylsalicylic Acid)
阿米卡星（丁胺卡那霉素）
Amikacin(Amikin)
扑热息痛（对乙酰氨基酚）
Paracetamol
(Acetaminophen)
庆大霉素
Furazolidone(furoxone)
西咪替丁（甲氰咪胍）
Cimetidine(tagamet)
诺氟沙星（氟哌酸）
Norfloxacin
胃仙U
Weisen-U
氧氟沙星（氟嗪酸）
Ofloxacin(tarivid)
颠茄
Belladonna
环丙沙星（环丙氟哌酸）
Ciprofloxacin
溴甲阿托品（胃疡平）
四环素
Tetracycline
二氧丙嗪（克咳敏）
Dioxopromethazine
土霉素
O）
Salbutamol
氯霉素
Chloramphenicol
(chloromycetin)
六、消化系统用药
磺胺嘧啶（磺胺哒嗪）
Sulfadiazine(SD)

中国药典附录Ⅰ(A-Z)中英文对照

（附录Ⅰ制剂通则）Appendix ⅠGeneral Requirements for Prearations（丸剂）ⅠA Pills丸剂系指药材细粉或药材提取物加适宜的黏合剂或其他辅料制成的珠形或类球形制剂，分为蜜丸、水蜜九、水丸、糊丸、蜡丸和浓缩丸等类型。

Pills are spherical or spherical-like solid dosage forms made of finely powdered crude drugs or crude drug extracts, proper binders or other excipients. They are classified into honeyed pills, water-honeyed pills, watered pills, pasted pills, concentrated pills waxed pills and concentrated pills etc.蜜丸系指药材细粉以蜂蜜为黏合剂制成的丸剂。

其中每丸重量在0.5g( 含0.5g)以上的称大蜜丸，每丸重量在0.5以下的称小蜜丸。

Honeyed pills are made of fine powder of crude drugs, using honey as binder. Among them, pills weighing more than 0.5g (including 0.5g) per pill are big honeyed pills, pills weighing less than 0.5g per pill are small honeyed pills.水蜜丸系指药材细粉以蜂蜜和水为黏合剂制成的丸剂。

Water-honeyed pills are made of fine powder of crude drugs, using honey and water as binders.水丸系指药材细粉以水（或根据制法用黄酒、醋、稀药汁、糖液等）为黏合剂制成的丸剂。

英国药典二氧化硅含量标准-概述说明以及解释

英国药典二氧化硅含量标准-概述说明以及解释1.引言1.1 概述概述部分的内容可以介绍英国药典和二氧化硅含量标准的背景和重要性。

英国药典（British Pharmacopoeia）是英国政府主导的药典，旨在确保药品的质量和安全，并提供关于药品的规范和标准。

它是全球最古老、最为广泛使用的药典之一，被广泛认可和接受。

二氧化硅是一种常见的化学物质，具有广泛的应用领域。

在医药工业中，二氧化硅常用作药品的填充剂、稳定剂和流变剂。

它不仅可以增加药品的体积，还可以提高药品的稳定性和流动性。

然而，不同的药品需要不同的二氧化硅含量，过多或过少的二氧化硅都可能会影响药品的质量和疗效。

因此，为了确保药品的一致性和质量，制定了二氧化硅含量的标准。

这些标准指定了药品中二氧化硅的最大和最小含量，以及什么样的测试方法可以用于测量二氧化硅含量。

这些标准的制定是基于科学研究和国际共识，旨在保证药品的质量和安全。

了解英国药典中关于二氧化硅含量的标准对于制药行业和药品生产者来说至关重要。

遵循英国药典的要求能够确保药品在生产过程中的质量和稳定性，并且能够满足患者的需要和期望。

对于药学研究者和相关领域的专业人士来说，了解这些标准还能够为他们的研究和开发提供指导和参考。

总而言之，英国药典中关于二氧化硅含量的标准起着至关重要的作用，不仅可以保证药品的质量和安全，还能够为药品生产者和研究人员提供指导和参考。

在药品生产和研究中，遵循这些标准能够确保药品的一致性和有效性，从而更好地满足患者的需求。

1.2 文章结构文章结构部分:文章的结构非常重要，可以帮助读者更好地理解和组织所阐述的内容。

本文将按照以下结构进行组织：第一部分是引言，主要包括概述、文章结构和目的三个方面。

在概述部分，将简要介绍英国药典中的二氧化硅含量标准的重要性和应用背景。

接下来，在文章结构部分，将详细介绍本文按照何种结构进行组织，在本文中的各个部分分别阐述的内容。

最后，明确本文的目的，即为读者提供关于英国药典中二氧化硅含量标准的全面了解。

英国药典2012 有关物质项译文

英国药典2012 有关物质项译文液相色谱法（见2.2.29）供试品溶液：取20mg本品用2mL乙腈溶解之后，用流动相A稀释至10.0mL。

对照溶液(a)：去1.0mL待测溶液用流动相A稀释至100.0mL。

再取该液1.0mL 用流动相A稀释至10.0mL。

对照溶液(b)：取布洛芬杂质B对照品1.0mL用乙腈稀释至10.0mL（溶液A）。

取20mg布洛芬标准品用2mL乙腈溶解，加入1.0mL溶液A，并用流动相A稀释至10.0mL。

对照溶液(c)：用1mL乙腈溶解布洛芬（峰鉴别用）对照品，并用流动相A稀释至5mL。

色谱柱：型号：l = 0.15 m, Ø = 4.6 mm；固定相：十八烷基键合硅胶，直径5µm；流动相：流动相A：将0.5体积的磷酸和340体积的乙腈、600体积的水混合，平衡后用水稀释至1000体积。

流动相B：乙腈时间（min）流动相A（体积百分比）流动相B（体积百分比）0-25 100 0 25-55 100→15 0→85相对保留时间：布洛芬保留时间约为21min，杂质J约为0.2min，杂质N约为0.3，杂质A约为0.9，杂质B约为1.1。

系统适应性：对照溶液（b）峰谷比：最小值1.5；Hp为杂质B的色谱峰顶点至基线的高度，Hv为布洛芬色谱峰和杂质B色谱峰分离的最低点至基线的高度。

根据需要调整流动相A中乙腈的浓度。

限度：杂质A、J、N：每种杂质均不超过对照溶液（a）色谱图中主成分峰面积的1.5倍（0.15%）；非特定杂质：每种杂质均不超过对照溶液（a）色谱图中主成分峰面积的0.5倍（0.05%）；总杂：不超过对照溶液（a）色谱图中主成分峰面积的2倍（0.2%）；忽略限度：对照溶液（a）色谱图中主成分峰面积的0.3倍（0.03%）。

杂质F 气相色谱法（2.2.28）- 使用常规步骤甲基化溶液：取1mLDMF-DMA和1mL吡啶，用乙酸乙酯稀释至10mL。

供试品溶液：取本品50.0mg于密封小瓶中，用1.0mL乙酸乙酯溶解，加入1mL甲基化溶液，密封，置于烘箱100°C高温加热20min。

药物用法拉丁文缩写词拉丁文缩写

一、药物用法拉丁文缩写词拉丁文缩写中文意义ac 饭前pc 饭后am 上午pm 下午sos 需要时，限用一次prn 必要时，长期备用医嘱st 立即，急速pN 每晚hs 睡前Qd 每日一次Bid 每日二次Tid 每日三次Qid 每日四次Q6h 每6小时一次12mn 中午12小时12n 24小时二,医嘱常用拉丁文缩写词拉丁文缩写中文意义aa 各po 口服ad us,int 内服ad us,ext 外用sig 用法,指示NPO 禁食Di 停用Rp 取ss 一半Ad 加至ps 适量Dil 稀释et 及,和MDS 混合后给予co;comp 复方的No;N 数目,个lnj 注射剂Tab 片剂pil 丸剂caps 腋囊剂Amp 安瓿剂Mist 合剂Emul 乳剂Syr 糖浆剂Tr 酊剂Neb 喷雾剂Garg 含漱剂Gtt;gutt 滴,滴眼剂collyr 洗眼剂Ocal 眼膏Liq 溶液剂Sol 溶液Lot 洗剂Linim 擦剂Crem 乳膏剂Ung 软膏剂past 糊剂Ol 油剂Enern 灌肠剂Supp 栓剂iH 皮下注射im 肌肉注射iv 静脉注射iv.gtt,iv.drip 静脉滴注sc，结膜下注射Sig 用法、指示qm 每晨1次qn 每晚1次hs 睡前ac 饭前pc 饭后st 立即sos 需要时prn 必要时po 口服ID 皮内注射H 皮下注射IM 肌肉注射IV 静脉注射iv.gtt iv.drip 静脉滴注5％G.S 5％的葡萄糖N.S 生理盐水G.N 葡萄糖盐水qd 每日一次bid 每日两次tid 每日三次qid 每日四次qh 每小时一次q2h 每两小时一次q4h 每四小时一次q6h 每六小时一次qn 每晚一次qod 隔日一次biw 每周两次hs 临睡前am 上午pm 下午St 立即DC 停止prn 需要时（长期）sos 需要时（限用一次，12小时内有效）12n 中午12点12mn午夜12点i.m. Injectio musculosa 肌肉注射i.v. Injectio venosa 静脉注射Lin. Inimentum 擦剂Liq. Liquor,liquidus 溶液，液体的Lit. Litrum 升Lot Lotio 洗剂Mist. Mistura 合剂Ml. Millilitrum 毫升Mg. Milligramma 毫克Muc. Mucilago 胶浆剂N Nocte 夜晚n.et.m Nocte et mane 在早晚Neb. Nebula 喷雾剂o.d. Omni die 每日O.D. Oculus dexter 右眼O.L. Oculus laevus 左眼O.S. Oculus sinister 左眼O.U. Oculi utrigue 双眼Ol. Oleum 油Om.bid. Omni biduo 每2日Om.d.(o.d.) Omni die 每日Om.hor.(o.h.) Omni hora 每小时Om.man. Omni mane 每日早晨Om.noc.(o.n.)Omni nocte 每日晚上p.c. Post cibos 饭后p.o. Per os 口服Pil. Pilula 丸剂p.j. Post jentaculum 早饭后p.m. Post meridiem 午后p.prand. Post prandium 午饭后Pcoen. Post coenam 晚饭后Pro us.ext Pro usu externo 外用内用，内服Pro us.med. Pro usu medicinali 药用Pro us.vet. Prousu veterinario 兽医用Pulv. Pulvis 粉剂、散剂Pt. Partes 部分p.r.n. Pro kre nata 必要时q.d. Quaque die 每日q.i.d. Quarter in die 每日4次q.h. Quaque hora 每1小时每4小时q.l. Quantum libet 任意量q.n. Quante nocte 每日晚上q.s. Quantum sufficit 足够量Quantum satis 足够量，适量q.semih. Quaque semihora 每半小时r.;rad Radix 根Rec Recens 新鲜的Rp. Recipe 取Rhiz. Rhizoma 根茎s.;sig. Signa,signetur 标记，指示s.i.d Semel in die 每日1次s.l Saccharum lactis 乳糖s.o.s Si opus(est)sit 需要时Sem. Semen 种子Ser.;syr. Sirupu,ssyrupus 糖浆Solut. Solutio 溶液Semih. Semihora 半小时Sp. Spiritus 醵剂Stat.;st Statim 立刻，立即Supp. Suppositouium 栓剂每日3次t.;tr. Tinctura 酊剂Troch. Trochscus 锭剂，糖锭Tab. Tabella 片剂Us. Usus 应用，用途Ug.;ung. Unguentum 软膏Us.ext. Usus externus 外用Us.int. Usus internus 内服Ut dict Ut dictum 依照嘱咐Vesp. Vespere 晚上处方上左上角的RP代表“请取”的意思，如果某种药后面是qd、bid、tid,分别代表每日一次、每日两次、每日三次。

药物分析常用英语词汇

药物分析专业英语词汇表Aaｂsorｂanｃe 吸收度aｂｓｏrbａncｅratiｏ吸收度比值aｂｓｏrpｔｉoｎ吸收absｏrpｔｉon curｖe 吸收曲线absorption coeffiｃienｔ吸收系数accｕrate vａｌue 准确值Aciｄ—dyeｃolormｃｔy 酸性染料比色法acidimcty 酸量法aciｄitｙ酸度aｃtivitｙ活度adjusted reｔeｎｔiｏnｔime调整保留时间ａbsorbｅnt 吸收剂ａｂsorption吸附aｌkalｉniｔy 碱度alumina氧化铝,矾土ambiｅnｔtｅmperａtuｒe 室温ammoｎiｕm ｔhiocｙａｎaｔe 硫氰酸铵analytｉcal ｑuaｌｉtｙco ｎtrol 分析质量控制ａnhydroｕｓsubｓtａnｃe 干燥品ａntioxidａｎt抗氧剂appliｃａtｉon ｏf saｍple 点样area normａｌiｚａtｉon ｍethod 面积归一法aｒsｅnic砷arsenｉｃsｐｏrｔ砷斑as ｓａy含量测定assａy ｔoleranｃ e 含量限度ａttenｕation 衰减aciｄbuｒetｔe 酸式滴定管ａlkalｉｂｕｒette 碱式滴定管a mortar研钵Ｂbａck extracｔｉon 反萃取band absorｐtion 谱带吸收batcｈ批batch nｕmbｅｒ批号Bentｔendｏrlｆmethｏd 白田道夫法ｂｅtweeｎｄay pｒeｃision 日间密度精ｂiotrａnｓfｏrmａtion 生物转化blaｎk t ｅｓt空白试验boilinｇｒaｎgｅ沸程British Pharmacoｐeiａ英国药典bromaｔe ｔitration溴酸盐滴定法bｒomine metｈｏd 溴量法ｂｒoｍotｈymol bｌue 溴麝香酚蓝bｕｌｋdrug 原料药ｂy—product副产物brｅaｋer 烧杯burettｅｇlaｓs beaｄnｏzz ｌe滴定管bｒowｎａｃid bｕrette 棕色酸式滴定管Ｃｃａlibratｉon cｕrve 校正曲线cａlｏmｅｌelectｒodｅ甘汞电极caloｒimetry量热分析capacity fａctor 容量因子ｃaｐiｌlａｒｙｇaｓcｈromatoｇrapｈy毛细管气相色谱法caｒrier gaｓ载气chａracteristｉcｓdescrｉptｉｏn 性状cｈelａtｅcｏｍpound螯合物chemical equivalent 化学当量Ｃhinｅse phaｒｍａｃｏpｅia 中国药典Chｉnese mateｒiaｌmｅdicine 中成药Cｈinesｅmatｅrial mｉｄical ｐreparaｔioｎ中药制剂ｃhiraｌ手性的chｉｒal ｃarｂon ａｔoｍ手性碳原子cｈrｏmatogram 色谱图chromatogrａpｈy 色谱法cｈromａｔographｉc cｏlｕｍn 色谱柱ｃhroｍatographic cｏnditioｎ色谱条件clarit ｙ澄清度cｏeffｉcｉｅnt oｆdｉｓtriｂutioｎ分配系数coeffiｃiｅnt of varｉation变异系数colｏr ｃhaｎge ｉnteｒval 变色范围coｌｏｒreａctｉoｎ显色反应coｌoｒmeｔry 比色法ｃolumn effｉc ｉeｎcy 柱效ｃｏlｕmn temperａtｕre 柱温coｍpaｒativｅｔest比较试验ｃoｍpleｔeness of sｏlutiｏn 溶液的澄清度cｏnjｕgatｅ缀合物cｏｎceｎｔratiｏn—ｔiｍe curvｅ浓度时间曲线coｎfｉdence ｉnｔerｖal 置信区间coｎfidence level 置信水平coｎtrｏlled ｔriaｌ对照试验correlaｔion coｅfficiｅnt 相关系数cｏｎtrast tｅst 对照试验conｇeａlｉｎg poiｎt 凝点cｏnｔent unifaｒｍｉtｙ装量差异coｎtｒolleｄtｒial 对照试验correｌａtioｎcoeffiｃient相关系数ｃontrast test 对照试验counｔer ｉon 反离子ｃresaｌred 甲酚红ｃｕveｔte ceｌl 比色池ｃyａnide氰化物cas ｓerolｅsｍalｌ勺皿Dｄeａd—ｓtoｐｔｉtｒａtion 永定滴定法ｄｅaｄtiｍe死时间deflection 偏差deflection point 拐点deｇaｓsiｎg脱气deionizｅd waｔer去离子水dｅliｑuｅｓｃence潮解ｄepreｓsoｒsubstaｎces tｅsｔ降压物质检查法deｓiｃcａnt 干燥剂detｅction 检查develｏpｉng reaｇent 展开剂develｏｐing chambeｒ展开室dev ｉａtiｏｎ偏差ｄｅxtrosｅ右旋糖diａsｔeｒeoisｏmｅｒ非对映异构体ｄiａzotｉzatiｏn 重氮化diｆｆｅrential thｅrｍal anaｌｙsｉs 差示热分析法differeｎｔｉal scanninｇcａlorｉｍetｒｙ差示扫描热法Gｕtzeiｔ古蔡ｄａy to daｙprｅcision 日间精密度ｄｉsso ｌution 溶出度dirｅｃtｉnjectioｎ直接进样2,６-dｉchlorindophenol ｔitration 2,6-二氯靛酚滴定法digestion 消化diphａｓtｉc titｒaｔiｏn 双向滴定diｓiｎｔegｒatioｎｔest 崩解试验diｓpersiｏn 分散度ｄissolubilit ｙ溶解度dissolｕtionｔｅsｔ溶解度检查diｓtｉｌling raｎgｅ滴程ｄｉstribution chｒomａtoｇraphy 分配色谱d ｏse 剂量ｄrug qualiｔｙｃｏntrｏｌ药品质量控制dryiｎg to constant weig ｈt 干燥至恒重dupliｃatｅｔesｔ重复试验dｉsk method ｗaｔer method压片法Eｅfｆectivｅconｓｔituenｔ有效成分effeｃtive pｌate ｎumber 有效板数efｆectiｖe of cｏｌumn 柱效electｒophoｒesｉs 电泳elｉminａtｉon 消除eｌuate洗脱液elutiｏn 洗脱enamtiｏmer 对映体end abｓoｒpti ｏn 末端吸收ｅnｄogenous sｕbstａnces内源性物质enzｙｍｅd ｒug 酶类药物enzｙmｅinductｉon 酶诱导enzyme iｎhiｂｉtｉon 酶抑制epimer 差向异构体equｉlibriｕｍconsｔaｎt 平衡常数ｅrroｒin voｌuｍet ｒic analysis 容量分析误差exclusion ｃhroｍａtograｐｈy排阻色谱法expiraｔion ｄatｅ失效期extｅrｎalｓｔandａrd ｍethod 外标法ｅxｔｒaｃｔ提取物exｔration ｇraviｍetry提取重量法eｘｔrａｃtiｏn titrati ｏn 提取容量法extrapｏlated method外插法Erlｅnmeyer flask锥形瓶evａporaｔing disｈｓmaｌl 蒸发皿eloｎgatｅd bｕlb胖肚ｅlｅctroniｃbalaｎce MeｔｔlｅrＡL２04MeｔｔlerＡL20４电子天平Ffactor 系数ｆehling’s reaction 斐林实验filter 过滤ｆｉnenｅsｓof the parｔicleｓ颗粒细度ｆｌｏw rate 流速fｌｕoresｃｅｎt aｇenｔ荧光剂flｕoｒescｅｎce specｔrophotoｍetry 荧光分光光度法fluｏrｅscence dｅte ｃtioｎ荧光检测器ｆluorescｅnce ａｎalｙｓｉｓ荧光分析法foreignｐｉgment 有色杂质ｆｏrmulａrｙ处方集ｆree游离freezｉng tesｔ冻结试验fｕｓｅd silｉca 熔融石英ｆilteｒpａｐer 滤纸Ｇgａs cｈromaｔogｒaphｙ气相色谱法ｇas-liquid ｃhｒｏmatogｒaphy气液色谱法ｇas puriｆiｅｒ气体净化器Ｇeneral iｄentiｆicatiｏn tesｔ一般鉴别试验geｎｅral ｎotｉcｅｓ凡例Genｅral requｉｒementｓ(药典)通则ｇooｄclinｉｃal pracｔicｅｓ药品临床管理规范goｏｄlabora ｔorｙｐｒａctｉceｓ药品实验室管理规范gｏoｄｍａnufａｃturing practices(GMP)药品生产质量管理规范good supply practi ｃes(GSP)药品供应管理规范gｒaｄienｔelutｉｏｎ梯度洗脱grａｔｉｎg 光栅ｇravimｅｔric ｍｅtｈod 重量法Gｕtｚeit test 古蔡(检砷）法glａss funneｌlｏｎｇstem 玻璃漏斗grad cyｌｉｎdｅr 量筒ｇlass ｒod玻棒ｇraduated pｉpeｔｔeｓ刻度吸管ＧC气相色谱Hｈｅaｖy ｍetａｌ重金属hａlf peak wiｄtｈ平峰宽hｅat condｕctiviｔy热导率height equｉvaｌent to a the ｏretｉcal plate 理论塔板高度hｅｉｇht of an eｆfｅctive p ｌａte 有效塔板高度high-pｅrｆorｍanｃe liquｉd ｃhromaｔoｇraphy (ＨPLC)高效液相色谱法hｉgh-perｆormance thin-lａyer chｒoｍaｔｏgrａｐhｙ(ＨＰTＬC)高效薄层色谱法hydraｔｅ水合物hydrｏlyｓis 水解hｙdrｏphｉlicitｙ亲水性hydro ｐｈoｂｉcitｙ疏水性hydrｏｘyl vａlｕｅ羟值hypｅｒchromi ｃefｆect浓色效应hypｏcｈrｏmicｅｆfｅct淡色效应ＨＨS－tyｐe ｃoｎstant temｐｅrature watｅr bath HＨS型恒温水锅ＨPLC 高效液相色谱法Ｉidentｉfiｃatｉon 鉴别igniｔiｏｎto cｏnstant wei ｇｈt 灼烧至恒重iｍmobile phase 固定相immunoasｓay 免疫测定ｉmpｕriｔy 杂质inａctiｖation 失活ｉｎｄex 索引inｄｉcａｔor elｅcｔroｄ e 指示电极indicatoｒ指示剂iｎhibｉtｏr 抑制剂iｎjectiｎg sｅptｕm 进样隔膜胶垫insｔrumental aｎal ｙsis 仪器分析injｅｃtｉｏn valｕe 进样阀ｉｎsulｉｎassay 胰岛素生物检测法iｎtegrａｔor积分仪inｔerｃept 截距intｅrfａce 接口inｔernal ｓtaｎdarｄｓubstaｎce内标物质Ｉｎｔernational unit 国际单位in vｉｔrｏ体外i ｎvivｏ体内ｉodiｄｅ碘化物iodofoｒm reatiｏｎ碘仿反应iｏdomｅtｒy 碘量法ｉｏn ｐａiｒcｈｒomatｏgｒaｐhｙ离子对色谱ioｎsupｐresｓion 离子抑制ｉｏn suｐpreｓsｉoｎ离子抑制ionic sｔｒength 离子强度ion-ｐairing agent 离子对试剂ioni ｚation 电离ｉｓoaｂsｏrptｉve poｉnt 等吸收点ｉsocratic elutioｎ等溶剂组成洗脱isｏeｌeｃtｒic ｐoｉｎt 等电点isoosmotic ｓｏluｔｉｏn 等渗溶液irrｅverｓible ｉndｉcator 不可逆指示剂irreｖeｒsiblｅpｏｔential 不可逆电位ﻩＫKaｒl Ｆischer tｉtratｉｏn 卡尔-费舍尔滴定Kjeldａｈl ｍｅtｈod fｏｒnitrogen凯氏定氮法Kｏber r ｅａgent 科伯试剂Kｏｖａｔs reteｎtｉｏｎinde ｘ科瓦茨保留指数Llabｅlled amount 标示量leａｄinｇpeａk 前延峰ｌevｅlｉｎｇeffect 均化效应licenseｄpharmacist 执业药师limit ｃon ｔrｏl限量控制ｌimｉt of ｄeteｃtiｏn 检测限lｉmitｏｆquantitaｔion定量限ｌｉmiｔtes ｔ杂质限度试验loｓｓon ｄryiｎｇ干燥失重low pｒeｓsｕre ｇrａdｉeｎt pump 氧压梯度泵liｎeaｒiｔｙand ｒa ｎge线性及范围ｌiｎeａrｉty scaｎｎｉng线性扫描luｍinｅscence 发光litmus paper石蕊试纸ｌyophilizａtｉｏｎ冷冻干燥Mﻩmaｉｎconstitｕeｎt 主成分make-up ga ｓ尾吹气ｍaltol reaction 麦芽酚试验Marｑuis tｅst 马奎斯试验masｓanalyzeｒdetｅctor 质量分析检测器maｓs ｓpeｃｔroｍetｒiｃanalysiｓ质谱分析masｓspeｃtrum质谱图mｅan dｅviａtion 平均偏差meltinｇpoｉnｔ熔点meltinｇraｎge熔距ｍｅｔａboｌite 代谢物metaｓtａble iｏn 亚稳离子micellar chroｍatｏgrａphy 胶束色谱法microaｎaｌysis 微量分析microcrysｔaｌ微晶m ｉｃrodialysis微透析migｒation tｉｍe 迁移时间Ｍiｌliｐorｅfiltratioｎ微孔过滤mo ｂile phasｅ流动相ｍolｅculａｒfoｒmｕla 分子式ｍonitor 检测monochrｏmator 单色器ｍｏn ｏgｒaｐhs 正文Nnatural product 天然产物Ｎessｌer’s reａgenｔ碱性碘化汞试液nｅutｒaliｚａtｉon 中和nｉtrｏgen conｔeｎt总氮量nonaqueouｓacid-ｂaｓe tｉtration非水酸碱滴定nonpreｓｃription dru ｇ,ｏver ｔhe ｃｏｕｎteｒｄruｇs 非处方药ｎoｎｓｐeciｆｉc impｕrｉty一般杂质non-volａｔiｌe ｍａtter 不挥发物nｏrｍａl pｈa ｓe 正相normａｌiｚaｔiｏn 归一化法Nｅｓslｅｒcｏloｒｃoｍpaｒｉson tｕbe 纳氏比色管Onotice 凡例octaｄｅcyl silａne bondeｄsilｉcａｇeｌ十八烷基硅烷键合硅胶odorless辛基硅烷odoｒｌesｓ无臭ｏfｆicial ｎamｅ法定名officiａl teｓｔ法定试验on-coｌｕmn detecto ｒ柱上检测器on-cｏｌｕmn iｎｊectiｏｎ柱头进样on tｈe ｄrｉed ｂasｉs按干燥品计opalescenｃe 乳浊optical actｉv ｉty 光学活性optｉｃal isomeｒｉsm 旋光异构opticａｌｐｕriｔy 光学纯度ｏrgａnic volaｔｉle iｍpuriｔｉes 有机挥发性杂质oｒtｈogｏnａl ｔeｓt 正交试验ｏrｔhopheｎａnthroline 邻二氮菲outlier 可疑数据overｔones 倍频封oxidatioｎ-reducｔiｏn titｒatiｏn 氧化还原滴定oxygen ｆlaｓk comｂusｔion氧瓶燃烧Ppaｃked coｌumｎ填充柱paｃｋｉnｇmaterｉaｌ色谱柱填料paｌlaｄium ｉｏn cｏloｒimｅtｒy 钯离子比色法p ａreｎt ion 母离子pａrtiｃulａtｅmattｅｒ不溶性微粒ｐａrｔｉｔion co ｅfficｉenｔ分配系数patｔｅrn recogniｔion(ｐpｍ）百万分之几peak sｙmmｅtr ｙ峰不对称性peak ｖalｌey 峰谷peak width at half heｉghｔ半峰宽peｒcenｔtransmittanｃe 透光百分率pH ｉｎdiｃａtor ａｂsoｒｂanｃe ratio method pＨ指示剂吸光度比值法ｐhａrmａｃeuticaｌanalysｉs药物分析p ｈarmacopeｉa 药典phａｒｍacｙ药学photｏmeteｒ光度计poｌariｍetｒｙ旋光测定法polariｔy极性ｐolydexｔrａn ｇel 葡聚糖凝胶potｅntiomeｔｅr 电位计poｔｅｎtiometric ｔｉtｒation 电位滴定法prｅcipitatioｎform 沉淀形式prｅcｉsion 精密度pr ｅpａration 制剂pｒｅscrｉption dｒuｇ处方药pretｒeatｍｅnt 预处理primaｒｙstandaｒｄ基准物质ｐriｎcipal cｏｍｐonenｔanalｙsiｓ主成分分析ｐｒotｏtype ｄruｇ原型药物ｐurifｉcatiｏｎ纯化ｐuｒity 纯度pyrｏgeｎ热原pycnomeｔeｒmｅthｏd比重瓶法plastic ｗash ｂottｌe洗瓶platfoｒm ｂalanｃ e 天平pipｅｔte 移液管ｐyknoｗmetｅr fｌaｓｋs 容量瓶Ｑquality ｃｏntｒol 质量控制qｕality eｖaluatiｏn 质量评价quaｌity ｓtandard 质量标准quａntｉtatｉve ｄeｔｅrmi ｎation 定量测定quａntitａｔive anａlysiｓ定量分析ｑuａsi－ｍolecular i ｏn 准分子离子Rrａceｍizatiｏn 消旋化randoｍsａmpling随机抽样ｒaｔｉonａl ｕse oｆdｒｕg 合理用药readily carbonｉzａｂlｅsubstance 易炭化物质ｒｅａgeｎｔspｒayｅr试剂喷雾剂recovery 回收率ｒeferenｃeｅｌecｔrodｅ参比电极relａtｅd substancｅ相关物质relａｔｉve deｎｓｉty 相对密度reｌative iｎｔensiｔy相对强度repeataｂilｉtｙ重复性repliｃate ｄｅterminａtiｏn 平行测定reｐrｏｄucｉbiｌiｔｙ重现性residual ｂaｓic hydrｏlysis mｅthoｄ剩余碱水解法ｒesiduaｌlｉquid juｎｃtion pｏtentiａl 残余液接电位residuaｌｔitratiｏｎ剩余滴定residuce on iｇnitｉｏn 炽灼残渣ｒesoｌｕtioｎ分辨率respｏnse time 响应时间ｒetｅntioｎ保留reversed ｐｈase chroｍatograｐhｙ反相色谱法revｅｒse osmosis 反渗透ｒinse 淋洗rｏｂｕsｔｎｅss 可靠性ｒound 修约ｒeａgent ｂotｔｌeｓ试剂瓶round botto ｍflasｋ圆底烧瓶rubber suction bｕｌb洗耳球Ssａfｅty 安全性Ｓakａｇｕcｈi te ｓｔ坂口试验salｔbridge 盐桥sａltinｇｏu ｔ盐析saｍple appｌicａtor 点样器ｓamｐle ａpplｉcatｉon 点样saｍpliｎg 取样saｐｏnification value 皂化值ｓaｔｕrａteｄcaｌomeｌeｌｅｃtrode饱和甘汞电极ｓelｅct ｉviｔy 选择性ｓｉgniｆｉcant dｉｆferencｅ显著性水平sigｎiｆicanｔｔesｔin ｇ显著性检验sｉlｉcａget硅胶silvｅr chloride electrode氯化银电极ｓiｍilaｒity 相似性sodｉum dｏdecylsulｆaｔe 十二基酸钠solid-ｐhａsｅexｔraｃtｉon 固相萃取solｕbility 溶解度speciｆicａｂsorbancｅ吸收系数specifｉcａtio ｎ规格spｅcifiｃitｙ专属性sｐeｃｉｆiｃｒotａtｉoｎ比旋度specｉｆｉc ｗeight 比重ｓpiked 加入标准的spｌit iｎｊectｉon分流进样sｐraｙrｅa ｇｅnｔ显色剂sｔaｂiliｔｙ稳定性stａndaｒd ｃolｏrｓolution 标准比色液ｓtandard dｅｖｉａｔｉoｎ标准差stａndardiｚaｔion 标定standarｄｓubｓtaｎce 标准品statisticaｌerror 统计误差stｅｒility test 无菌试验stock solutiｏn 储备液stｏiｃｈｉoｍｅtriｃpoint 化学计量点storag ｅ贮藏sｔraｙlight 杂散光sｕｂsｔr ａte 底物suｂｓtituent 取代基ｓulfａte 硫酸盐ｓulｐhateｄａsh 硫酸盐灰分support 载体ｓuｓpensｉon 旋浊度swｅｌlｉｎg dｅgree 膨胀度sｙmmｅtry faｃtor对称因子ｓystｅｍａtic error 系统误差sｅpａratｉng fｕnnel 分液漏斗sｔｏpcock 玻璃活塞sciｓsorｓ剪刀spｉｒit laｍp 酒精灯silica ｇｅl G thiｎｌayer 硅胶G薄层板Tｔable 片剂ｔailing faｃtor 拖尾因子tailiｎg ｐeak 拖尾峰test ｓｏluｔion 试液therｍal aｎａlysis 热分析法theｒmal conｄｕctivｉtｙｄetｅctor 热导检测器theｒmｏgraviｍeｔric ａｎalysiｓ热重分析法Ｔhe United States Phaｒmacｏpoeiａ美国药典TｈｅＰhaｒmacopoeia of Jaｐａn 日本药局方tｈin laｙeｒchrｏmatoｇraphy薄层色谱ｔｈiｏchrome reactioｎ硫色素反应thｙｍoｌ百里酚ｔhyｍolphtｈａleiｎ百里酚酞tiｔｅr 滴定度thｒee-dimｅnｓionaｌchromaｔograｍ三维色谱图titrant 滴定剂tiｔｒation error 滴定误差titriｍetric ａnalysｉs 滴定分析法ｔoｌerａｎce 容许限ｔoｔal asｈ总灰分tｏtal qｕａｌｉty control 全面质量控制ｔrａdｉtiｏnal dｒｕgｓ传统药tｒaditｉｏnａl Chinese medicine 中药turbidaｎｃe 浑浊tuｒｂｉdimｅｔric assａy 浊度测定法turbidimｅtry 比浊度turbiｄity 浊度Uulｔrａｃｅntriｆugation 超速离心uｌtｒａｖiolet iｒｒaｄiatiｏn 紫外线照射ｕｎdｕe toxicitｙ异常毒性uｎifｏrm design 均匀设计ｕｎｉfoｒmiｔy oｆdｏｓage unｉｔｓ含量均匀度uｎｉformity ｏf ｖｏlume装量均匀性unｉfoｒmｉtｙｏf ｗeight 重量均匀性Vvalｉdｉtｙ可靠性ｖarｉaｎｃe 方差viscosiｔｙ粘度volaｔile oｉl dｅtｅｒminａtｉo ｎapparａtｕｓ挥发油测定器ｖolａtiｌizａtion 挥发性voｌumetricａnalysis容量分析voluｍetriｃsｏｌution 滴定液voluｍeｔｒｉc flasks 比重瓶Wｗａve leｎｇth 波长ｗave numbeｒ波数weｉghiｎｇbotｔlｅ称量瓶ｗｅｉｇhiｎg form 称量形式wｅｌl-clｏsed conｔａｉｎeｒ密闭容器white board 白瓷板Xxylｅｎｅｃyａｎol blｕｅFＦ二甲苯蓝FF xylenoｌoｒange二甲酚橙ZZｉgｚag scanｎing 锯齿扫描zwitterionｓ两性离子Zyｍolyｓis 酶解作用ｚｏne elecｔｒophｏresiｓ区带电泳。

药物缩写,别名,处方缩写整理

药物缩写，别名，处方缩写整理一药物拉丁缩写:GS（葡萄糖注射液）NS（生理盐水）NG（硝酸甘油）NE（去甲肾上腺素）PG（青霉素G）SMZ（磺胺甲恶唑）SG（磺胺脒）SB（碳酸氢钠）ABOB（吗啉胍）DXM（地塞米松）PAMBA（止血芳酸）TA T（破伤风）FU（氟脲嘧啶）RFP（利福平）EM（红霉素）ISO（异丙肾上腺素）Vit（维生素）二，医用别名：1（丁胺卡那霉素——阿米卡星）2;（醋酸泼泥松——强的松）3（头孢哌酮——先锋必）4（头孢塞肟钠——先锋7号）5（头孢唑林钠——先锋5号）6（头孢曲松钠——菌必治）7（苄星青霉素——长效青霉素）8（大观霉素——淋必治）9（利巴韦林——病毒唑）10（吗啉双呱——病毒灵）11（葡醛内酯——肝泰乐）12（百炎净——复方磺胺甲恶唑-SMZ）13（诺氟沙星——氟哌酸）14（呋喃妥因——呋喃坦定）15（呋喃唑酮——痢特灵）16（甲硝唑——灭滴灵）17（阿昔洛韦——无坏鸟甘）18（庆大霉素普鲁卡因——胃炎灵）19（庆大霉素碳酸必——肠炎宁）20（呋噻米——速尿）21（心律平——普罗帕酮）22（异博定——盐酸维拉帕米）23（硝酸异山梨酯片——消心痛）24（脑复新——盐酸吡硫醇）25（脑脉宁——盐酸托哌酮片）26（曲安奈德——康A——康尼克通）27（心的安——盐酸普萘洛尔）28（脑复康——吡拉西坦）29（硫酸软骨素——康的宁）30（肝安——15AA）（肾安——9AA）31（沙丁胺醇——硫酸舒喘宁）32（必嗽平——溴已新）33（咳必清——枸椽酸喷托维林片）34（脑溢嗪——盐酸桂利嗪）35（盐酸二氧嗪片——咳克敏）36（妇康片——炔诺酮片）37（化痰片——羧甲司坦片）38（维尔新——维生素E烟酸酯胶囊）39（螺内酯——安体舒通）40（西咪替丁——甲青咪瓜）41（胃舒平——氢氧化铝）42（甲疏咪唑——他巴唑）43（肾上腺色腙素——安洛血）44（扑尔敏——马来酸氯苯那敏）45（盐酸异丙嗪——非那根）46（碳酸氢钠——小苏打）47（706代血浆——羟乙基淀粉40氯化钠针）48（低份子右旋糖——右旋糖酐40葡萄糖针）49（酚磺乙胺——止血敏）50（罗通定——颅痛定）51（维生素B2——核黄素）52（维生素C——抗坏血酸）53（A TP——三磷酸腺苷酸）54（GM——庆大霉素）55（潘生丁——双嘧达莫）56（扑炎痛——贝诺酯）57（消炎痛——吲哚美辛）58（扑热息痛——对乙酰胺基酚）59（止血芳酸——氨甲苯酸）60（强力霉素——多西坏素）61（癣敌——硝酸溢康唑软膏）62（治癣必妥——联苯苄唑乳膏）63（维脑路通——曲克芦丁）64（氢氯噻嗪——双克片）65（黄体酮——醋酸甲羟孕酮）66（阿司匹林——乙酰水杨酸）67（吡罗昔康——炎痛喜康）68（盐酸黄莲素——盐酸小檗碱）69（双氯灭痛——双氯芬酸酯）70（强筋松——苯丙氨酯）71（酚酞片——果异片）72（甲氯普胺——胃复安）73（溴丙胺太林片——普鲁苯辛）74（牙痛水——樟脑水合氯醛酊）75（654-2——消旋山莨菪碱片）76（心脉宁——复方毛冬青氯贝酸铝）77（脉通——复方亚油酸乙酯胶丸）78（心痛定——硝苯地平）79（毛花洋地黄苷丙——西地兰）80（苯磺酸阿曲库铵——卡肌宁）81（杜冷丁——哌替啶）82（氨伽黄敏胶囊——速效伤风胶囊）83（乳酶生——表飞明（鸣））84（异烟肼——雷米封）85（卡托普利——克普定）头孢噻吩（先锋I) 头孢氨苄（先锋IV）头孢拉定（先锋VI) 强力霉素（多西环素）艾司唑仑（安定）他巴唑（甲巯咪唑）甲氧氯普胺（胃复安）复方丹参（香丹）氨苄青霉素（氨苄西林）氟桂利嗪（西比定）复方氢氧化铝（胃舒平）奥美拉唑（洛赛克）琥乙红霉素（利君沙）吲哚美辛（消炎痛）硝酸异山梨酯（消心痛）硝苯地平（心痛定）普萘洛尔（心得安）硫酸新霉素滴眼液（的确当）硝苯地平缓释片（圣通平）诺氟沙星（氟哌酸）复方新诺明（百炎净）沙丁胺醇（舒喘灵）头孢曲松钠（菌必治）水飞蓟宾葡甲胺片（西利复安）酒石酸美托洛尔（倍他乐克）维拉帕米（异搏定）桂利嗪（脑益嗪）普罗帕酮（心律平）格列齐特（达美康）格列本脲（优降糖）格列吡嗪（美吡达）曲咪新乳膏（皮康霜）曲安奈德（肤疾灵）林旦软膏（疥得治）酮康他唑（皮康王）三、处方缩写:qd/sid（每天一次）bid（一日两次）tid（一日三次）qid（每天四次）qn/on（每晚）qh（每小时一次）q2h（每两小时一次）q3h（每三小时一次）类推hs（睡前）ac（饭前）Pc（饭后）aj（空腹时）am（上午）pm（下午）om（每晨）sos（需要时用一次）st（立即）sig（标注，用法）rp（请取药）po（口服）inj（注射剂）mixt（合剂）tad（片剂）sol（溶液）co（复方）pr（灌肠）id（皮内注射）iv（静脉注射）ivgtt（静脉点滴）ih（皮下注射）im（肌肉注射）。

药物拉丁文缩写

药物拉丁文缩写药物拉丁文缩写一药物拉丁缩写:GS（葡萄糖注射液）NS（生理盐水）NG（硝酸甘油）NE（去甲肾上腺素）PG（青霉素G）SMZ（磺胺甲恶唑）SG（磺胺脒）SB（碳酸氢钠）ABOB（吗啉胍）DXM（地塞米松）PAMBA（止血芳酸）TAT（破伤风）FU（氟脲嘧啶）RFP（利福平）EM（红霉素）ISO（异丙肾上腺素）Vit（维生素）二医用别名：1（丁胺卡那霉素——阿米卡星）2（醋酸泼泥松——强的松）3（头孢哌酮——先锋必）4（头孢塞肟钠——先锋7号）5（头孢唑林钠——先锋5号）6（头孢曲松钠——菌必治）7（苄星青霉素——长效青霉素）8（大观霉素——淋必治）9（利巴韦林——病毒唑）10（吗啉双呱——病毒灵）11（葡醛内酯——肝泰乐）12（百炎净——复方磺胺甲恶唑-SMZ）13（诺氟沙星——氟哌酸）14（呋喃妥因——呋喃坦定）15（呋喃唑酮——痢特灵）16（甲硝唑——灭滴灵）17（阿昔洛韦——无坏鸟甘）18（庆大霉素普鲁卡因——胃炎灵）19（庆大霉素碳酸必——肠炎宁）20（呋噻米——速尿）21（心律平——普罗帕酮）22（异博定——盐酸维拉帕米）23（硝酸异山梨酯片——消心痛）24（脑复新——盐酸吡硫醇）25（脑脉宁——盐酸托哌酮片）26（曲安奈德——康A——康尼克通）27（心的安——盐酸普萘洛尔）28（脑复康——吡拉西坦）29（硫酸软骨素——康的宁）30（肝安——15AA）（肾安——9AA）31（沙丁胺醇——硫酸舒喘宁）32（必嗽平——溴已新）33（咳必清——枸椽酸喷托维林片）34（脑溢嗪——盐酸桂利嗪）35（盐酸二氧嗪片——咳克敏）36（妇康片——炔诺酮片）37（化痰片——羧甲司坦片）38（维尔新——维生素E烟酸酯胶囊）39（螺内酯——安体舒通）40（西咪替丁——甲青咪瓜）41（胃舒平——氢氧化铝）42（甲疏咪唑——他巴唑）43（肾上腺色腙素——安洛血）44（扑尔敏——马来酸氯苯那敏）45（盐酸异丙嗪——非那根）46（碳酸氢钠——小苏打）47（706代血浆——羟乙基淀粉40氯化钠针）48（低份子右旋糖——右旋糖酐40葡萄糖针）49（酚磺乙胺——止血敏）50（罗通定——颅痛定)51（维生素B2——核黄素）52（维生素C——抗坏血酸）53（ATP——三磷酸腺苷酸）54（GM——庆大霉素）55（潘生丁——双嘧达莫）56（扑炎痛——贝诺酯）57（消炎痛——吲哚美辛）58（扑热息痛——对乙酰胺基酚）59（止血芳酸——氨甲苯酸）60（强力霉素——多西坏素）61（癣敌——硝酸溢康唑软膏）62（治癣必妥——联苯苄唑乳膏）63（维脑路通——曲克芦丁）64（氢氯噻嗪——双克片）65（黄体酮——醋酸甲羟孕酮）66（阿司匹林——乙酰水杨酸）67（吡罗昔康——炎痛喜康）68（盐酸黄莲素——盐酸小檗碱）69（双氯灭痛——双氯芬酸酯)70（强筋松——苯丙氨酯）71（酚酞片——果异片）72（甲氯普胺——胃复安）73（溴丙胺太林片——普鲁苯辛）74（牙痛水——樟脑水合氯醛酊）75（654-2——消旋山莨菪碱片）76（心脉宁——复方毛冬青氯贝酸铝）77（脉通——复方亚油酸乙酯胶丸）78（心痛定——硝苯地平）79（毛花洋地黄苷丙——西地兰）80（苯磺酸阿曲库铵——卡肌宁）81（杜冷丁——哌替啶）82（氨伽黄敏胶囊——速效伤风胶囊）83（乳酶生——表飞明（鸣））84（异烟肼——雷米封）85（卡托普利——克普定）头孢噻吩（先锋I)头孢氨苄（先锋IV）头孢拉定（先锋VI)强力霉素（多西环素）艾司唑仑（安定）他巴唑（甲巯咪唑）甲氧氯普胺（胃复安）复方丹参（香丹）氨苄青霉素（氨苄西林）氟桂利嗪（西比定）复方氢氧化铝（胃舒平）奥美拉唑（洛赛克）琥乙红霉素（利君沙）吲哚美辛（消炎痛）硝酸异山梨酯（消心痛）硝苯地平（心痛定）普萘洛尔（心得安）硫酸新霉素滴眼液（的确当）硝苯地平缓释片（圣通平）诺氟沙星（氟哌酸）复方新诺明（百炎净）沙丁胺醇（舒喘灵）头孢曲松钠（菌必治）水飞蓟宾葡甲胺片（西利复安）酒石酸美托洛尔（倍他乐克）维拉帕米（异搏定）桂利嗪（脑益嗪）普罗帕酮（心律平）格列齐特（达美康）格列本脲（优降糖）格列吡嗪（美吡达）曲咪新乳膏（皮康霜）曲安奈德（肤疾灵）林旦软膏（疥得治）酮康他唑（皮康王）三、处方缩写:qd/sid（每天一次）bid（一日两次）tid（一日三次）qid（每天四次）qn/on（每晚）qh（每小时一次）q2h（每两小时一次）q3h（每三小时一次）类推hs（睡前）ac（饭前）Pc（饭后）aj（空腹时）am（上午）pm（下午）om（每晨）sos（需要时用一次）st（立即）sig（标注，用法）rp（请取药）po（口服）inj（注射剂）mixt（合剂）tad（片剂）sol（溶液）co（复方）pr（灌肠）id（皮内注射）iv（静脉注射）ivgtt（静脉点滴）ih（皮下注射）im（肌肉注射）药物别名普萘洛尔－心得安阿替洛尔－胺酰心安硝酸异山梨酯－消心痛硝苯地平－心痛定曲克芦丁－维脑路通氢氧化铝-胃舒平沙丁胺醇－舒喘灵醋酸甲羟孕酮－安宫黄酮甲氧氯普胺－胃复安（灭吐灵）甲硝唑－灭滴灵去甲肾上腺素－正肾素肾上腺素－副肾素15AA－肝安9AA－肾安消旋山莨菪碱－654-2头孢噻肟钠－治菌必妥头孢曲松纳－曲而松喷托维林－咳必清诺氟沙星－氟哌酸呋喃唑酮－痢特灵洛贝林－山梗菜碱尼可刹米－可拉明拉米夫定－贺普丁吲哚美辛－消炎痛吡罗昔康－炎痛喜康复方氨基比林－安痛定去痛片－索密痛酚氨咖敏－扑感敏利巴韦林－病毒唑小檗碱－黄连素异烟肼－雷米封胞磷胆碱－胞二磷胆碱乙酰谷酰胺－醋谷胺罗痛定－颅痛定氨咖黄敏胶囊－速效伤风胶囊苯海索－安坦苯妥英纳－大伦丁苯巴比妥钠－鲁米那吡硫醇－脑复新吡拉西坦－脑复康异丙酚－丙泊酚（得普利麻）维拉帕米－异博定间羟胺－阿拉明酚妥拉明－立其丁桂利嗪－脑益嗪去乙酰毛花苷－西地兰D普罗帕酮－心律平美西律－慢心律倍他司汀－培他啶卡托普利－巯甲丙脯酸复方甘草合剂－棕色合剂复方愈创木酚磺酸钾－非那根合剂碳酸氢钠－小苏打西咪替丁－甲氰咪胍干酵母－食母生多潘立酮－吗丁啉酚酞－果导葡醛内酯－肝泰乐复方甘草酸单胺－强力宁氢氯噻嗪－双克呋塞米－速尿螺内酯－安体舒通缩宫素－催产素肾上腺色综－安络血氨甲苯酸－止血芳酸酚磺乙胺－止血敏亚硫酸氢纳甲萘醌－维生素K3硫酸氢钠甲萘醌－维生素K4叶绿醌－维生素K1利血生－利可君双嘧达莫－潘生丁异丙嗪－非那根氯苯那敏－扑尔敏地塞米松－氟米松泼尼松龙－强的松龙泼尼松－强的松氢化可的松－皮质醇曲安奈德－康宁克通丙酸睾丸素－丙酸睾酮甲基睾丸素－甲睾酮己烯雌酚－乙底酚（求偶素）氯米芬－克罗米芬格列本脲－优降糖苯乙双胍－降糖灵甲巯咪唑－他吧唑丙基硫氧嘧啶－丙噻优多柔比星－阿霉素表柔比星－表阿霉素他莫昔芬－三苯氧胺地芬尼多－眩晕停亚叶酸钙－甲酰四氢叶酸钙维生素Ｃ－抗坏血酸氯化钠－生理盐水（N.S）葡萄糖－G.S氯化钠葡萄糖－G.N.S地西泮－安定艾司唑仑－舒乐安定氯硝西泮－氯硝安定咪达唑仑－力月西（咪唑安定）可待因－甲基吗啡布桂嗪－强痛定哌替啶－杜冷丁汞溴红溶液－红药水过氧化氢－双氧水高锰酸钾粉－P.P粉乙酰唑胺－醋氮酰胺阿米卡星－丁胺卡那霉素苄星青霉素－长效青霉素头孢噻吩－先锋1号头孢噻啶－先锋2号头孢氨苄－先锋4号头孢唑林纳－先锋5号头孢拉定－先锋6号头孢羟氨苄－先锋9号头孢哌酮－先锋必复方磺胺甲恶唑－复方新若明（SMZ）多西环素－强力霉素米若环素－美满霉素依托红霉素－无味红霉素阿昔洛韦－无环鸟苷异丙肾上腺素－喘息定依托泊苷－足叶乙甙林可霉素－洁霉素复方肝浸膏－肝铁片（力勃隆）。

bronopol- 英国药典09

BronopolGeneral NoticesC3H6BrNO4 200.0 52-51-7Action and useAntibacterial preservative.DEFINITIONBronopol is 2-bromo-2-nitropropane-1,3-diol. It contains not less than 99.0% and not more than 101.0% of C3H6BrNO4, calculated with reference to the anhydrous substance.CHARACTERISTICSWhite or almost white crystals or crystalline powder.Freely soluble in water and in ethanol (96%); slightly soluble in glycerol and in liquid paraffin.IDENTIFICATIONA. The infrared absorption spectrum, Appendix II A, is concordant with the reference spectrum of bronopol (RS 031).B. Dissolve 0.1 g in 10 ml of water, add 10 ml of 7.5M sodium hydroxide and, carefully with constant stirring and cooling, 0.5 g of nickel-aluminium alloy. Allow the reaction to subside, filter and carefully neutralise with nitric acid. The resulting solution yields reaction A characteristic of bromides, Appendix VI.C. Melting point, after drying over phosphorus pentoxide at a pressure not exceeding 0.7 kPa, about 130°, Appendix V A.TESTSAcidity or alkalinitypH of a 1% w/v solution, 5.0 to 7.0, Appendix V L.Related substancesCarry out the method for liquid chromatography, Appendix III D, using the following solutions. Solution (1) contains 0.2% w/v of the substance being examined in the mobile phase. For solution (2) dilute a volume of solution (1) with sufficient mobile phase to produce a solution containing 0.0002% w/v of the substance being examined. Solution (3) contains 0.001% w/v each of 2-methyl-2-nitropropan-1,3-diol and tris(hydroxymethyl)nitromethane in the mobileeach of 2-methyl-2-nitropropan-1,3-diol and tris(hydroxymethyl)nitromethane in the mobile phase. Solution (4) contains 0.0002% w/v each of 2-methyl-2-nitropropane-1,3-diol, 2-nitroethanol, sodium bromide and tris(hydroxymethyl)nitromethane and 0.2% w/v of the substance being examined in the mobile phase.The chromatographic procedure may be carried out using (a) a stainless steel column (15 cm × 4.6 mm) packed with octadecylsilyl silica gel for chromatography (5 µm) (Phenomenex Luna C18 (2) is suitable) and maintained at 35°, (b) as the mobile phase with a flow rate of 1 ml per minute a mixture of 189 volumes of water, 10 volumes of acetonitrile and 1 volume of a 10% v/v solution of orthophosphoric acid, adjusting the pH to 3.0 using 2M sodium hydroxide and (c) a detection wavelength of 214 nm.The test is not valid unless, in the chromatogram obtained with solution (4), the resolution factor between the peaks due to sodium bromide and tris(hydroxymethyl)nitromethane is at least 1.0 and the resolution factor between the peaks due to tris(hydroxymethyl)nitromethane and 2-nitroethanol is at least 1.5.For solution (1) continue the chromatography for 3 times the retention time of the principal peak. In the chromatogram obtained with solution (1) the areas of any peaks corresponding to 2-methyl-2-nitropropane-1,3-diol and tris(hydroxymethyl)nitromethane are not greater than the area of the corresponding peaks in the chromatogram obtained with solution (3) (0.5% of each) and the area of any other secondary peak is not greater than the area of the principal peak in the chromatogram obtained with solution (2)Sulphated ashNot more than 0.1%, Appendix IX A.WaterNot more than 0.5% w/w, Appendix IX C, Method I B. Use 5 g.ASSAYIn a flask fitted with a reflux condenser dissolve 0.4 g in 15 ml of water and add 15 ml of 7.5M sodium hydroxide. Slowly, with caution, add 2 g of nickel-aluminium alloy through the reflux condenser, agitating the flask whilst cooling under running water. Allow the mixture to stand for 10 minutes and boil for 1 hour. Cool and filter under reduced pressure, washing the condenser, flask and residue with 150 ml of water. Combine the filtrate and washings, add 25 ml of nitric acid and 40 ml of 0.1M silver nitrate VS, shake vigorously and titrate with 0.1M ammonium thiocyanate VS using ammonium iron(III) sulphate solution R2 as indicator. Repeat the operation without the substance being examined. The difference between the titrations represents the amount of silver nitrate required. Each ml of 0.1M silver nitrate VS is equivalent to 20.00 mg of C3H6BrNO4.STORAGEBronopol should be protected from light.。

常用药品拉丁文

头孢哌酮：Cefoperazone
头孢他啶：Ceftazidime
头孢克肟：Cefixime
头孢唑肟钠：Cefrizoxime
头孢匹罗：Cefpirome
头孢哌酮/舒巴坦(舒哌酮)：
Sulperazone
氨基糖甙类：
链霉素：Streptomycin
庆大霉素：Gentamycin
妥布霉素：Tobramycin
胃复安：Paspertin
扑尔敏：Toldrin
甘露醇：Mannitol
肌苷：Inosine
速尿：Lusix
常用药品拉丁文
cefpiromesulperazone氨基糖甙类
青霉素类：
青霉素钠：Penicillin
氨苄西林：Ampicillin
阿莫西林：Amoxicillin
双氯西林：Dicloxacillin
苯唑西林钠：Oxacillin
氯唑西林钠：Cloxacillin
哌拉西林钠：Piperacillin
头孢菌素类：
头孢氨苄Ⅳ：Cefalexin
头孢唑啉钠Ⅴ：Cefazolin
头孢拉定Ⅵ：Cefradine
头孢克洛：Cefaclor
头孢羟氨苄：Cefadroxil
头孢替唑：Ceftezole
头孢呋辛钠：Cefuroxime
头孢西丁：Cefoxitin
头孢噻肟钠：Cefotaxime
头孢曲松钠：Ceftriaxone
磷霉素：Fosfomycin
环丙沙星：Ciprofloxacin
诺氟沙星：Norfloxacin
氧氟沙星：Ofloxacin
左氧氟沙星：Levofloxacin
氟罗沙星：Fleroxacin

处方常用拉丁文缩写

处方常用拉丁文缩写缩写中文缩写中文q.d. 每日一次 amp. 安瓿b.i.d. 每日二次 aa 各t.i.d. 每日三次 ad 加到、至q.i.d 每日四次 q.s. 适量q.o.d. 隔日一次 co. 复方的q.h. 每小时一次 Rp. 取q.4h. 每四小时一次 S. 标记q.m. 每晨 D.S. 给予、标记q.n. 每晚 D.t.d. 给予同量h.s. 睡时 M.D.S. 混合、给予、标记a.c. 饭前 No. 数目p.c. 饭后 aq.dest 蒸馏水a.m. 上午 Sol. 溶液剂p.m. 下午 Inj 注射剂p.r.n. 必要时 Syr 糖浆剂s.o.s. 需要时用 Mist 合剂st! 立即 Emuls 乳剂cito! 急速地 Tinct 酊剂i.h. 皮下注射 Lot. 洗剂i.m. 肌肉注射 Linim 擦剂i.v. 静脉注射 Garg 含漱剂i.v.gtt 静脉滴注 Gutt. 滴眼剂us.ext 外用 Pulv 散剂o.l. 左眼 Tab. 片剂o.d. 右眼 Pil 丸剂kg 公斤（千克） Caps 胶囊g 克 Supp 栓剂mg 毫克 Ung. 软膏剂ug 微克 Ocul. 眼膏剂L 升 Ol. 油剂ml 毫升 U 单位：常用毒麻、限剧药物的作用、副作用、用量、极量及配伍禁忌1、吗啡药理作用：对中枢神经的作用：镇静、镇痛，对呼吸有抑制作用，可引起周围血管扩张而至血压下降，可使肠蠕动减弱，使膀胱扩约肌处于收缩状态，可引起皮肤血管扩张，血糖增加。

副作用：引起眩晕、呕吐、便秘、排尿困难、成瘾快。

用量：成人肌注8-10毫克，静点麻醉0.5毫克/公斤体重,术后镇痛1-2毫克注入硬膜外。

配伍禁忌：婴儿、老年人、呼吸功能不全及哺乳期忌用。

2、杜冷丁：药理作用：与吗啡相似，约相当于吗啡的1/10，有降低心肌的应激性，对心脏有直接抑制作用，心率加快，易引起体位性虚脱。

副作用：与吗啡相同，超量引起中枢兴奋。

英国药典Appendix XVI C翻译

第一部分Appendix XVI C. Efficacy of Antimicrobial Preservation (Ph. Eur. general text 5.1.3)如果药物制剂本身没有足够的抗菌活性，那么就应该加抗菌防腐剂。

在药品正常的储存和使用过程中，液体制剂特别是多剂量液体制剂，尤其需要添加防腐剂。

这样不仅可以阻止细菌繁殖、限制微生物污染；还可以防止细菌污染给患者身体带来的危害和对药品本身的污染。

抗菌防腐剂在GMP中不能被替代。

抗菌防腐剂的效果根据药物制剂的组成成分的不同、防腐剂加入的形式的不同、或使用容器或封口的不同而增强或减弱。

在最终的包装容器内的制剂，我们需要验证它在整个有效期内的抗菌活性。

这样才能保证在贮存过程中抗菌活性不会减弱。

样品从最终容器中取出时就需要立即进行验证了。

在药物制剂发展期间（注：研发Research & Development，D就是发展期间，将活性分子变成处方制剂的过程），应该需要证明药物制剂本身的抗菌活性。

如果没有就需要添加合适的防腐剂、或防腐剂能够保护制剂免于遭受微生物污染的不良效果和在贮存和使用过程中细菌的繁殖。

抗菌活性应该通过以下一系列测试来证实。

这些测试并不用于常规的对照目的。

测试抗菌防腐剂的有效性测试包括三方面内容：一、不论最后的包装容器是什么，都需要用规定的接种物，也就是合适的微生物对制剂进行攻击。

二、在规定的温度下贮存已接种制剂。

三、在一段时间间隔内抑制容器内的样本生长，然后计数这样被除去的样本中的菌数。

在测试条件下，如果在规定时间和温度下，接种后制剂中的菌落数有重大的下降或没有增加，那么药物制剂中防腐剂的作用就是可以接受的。

接受标准（即在规定时间内减少微生物的数量）随着制剂类型的不同而不同。

因为制剂类型的不同所达到的保护的程度也不同。

（见表5.1.3-1/2/3）。

微生物检测（见附录二）绿脓假单胞杆菌A TCC 9027; NCIMB 8626; CIP 82.118.金黄色酿脓葡萄球菌ATCC 6538; NCTC 10788; NCIMB 9518; CIP 4.83.白色念珠菌A TCC 10231; NCPF 3179; IP 48.72.黑曲霉A TCC 16404; IMI 149007; IP 1431.83.使用单菌株攻击而且设计微生物可以在合适的地方补充其他菌株或品种，这样就能代表可能的制剂污染。

胰酶-英国药典s2009

PancreatinGeneral NoticesAction and useEnzyme; treatment of pancreatic exocrine deficiency.PreparationsPancreatin GranulesGastro-resistant Pancreatin TabletsDEFINITIONPancreatin is a preparation of mammalian pancreas containing enzymes having protease, lipase and amylase activity. It may contain Sodium Chloride. Pancreatin contains in 1 mg not less than 1.4 Units of free protease activity, not less than 20 Units of lipase activity and not less than 24 Units of amylase activity.PRODUCTIONPancreatin is prepared in conditions designed to minimise the degree of microbial contamination.CHARACTERISTICSA white or buff amorphous powder.Soluble or partly soluble in water forming a slightly turbid solution; practically insoluble in ethanol (96%) and in ether.IDENTIFICATIONA. Triturate 0.5 g with 10 ml of water and adjust to pH 8.0 by the addition of 1M sodium hydroxide using cresol red solution as indicator. Divide the resulting solution into two equal portions. Boil one portion [solution (1)] and leave the other untreated [solution (2)]. To each add a few shreds of congo red fibrin, warm to 38° to 40° and maintain at this temperature for 1 hour. Solution (2) is stained red and solution (1) is colourless or not more than slightly pink.B. Triturate 0.25 g with 10 ml of water and adjust to pH 8.0 by the addition of 1M sodium hydroxide using cresol red solution as indicator. Divide the resulting solution into two equal portions. Boil one portion [solution (1)] and leave the other untreated [solution (2)]. Dissolve 0.1 g of soluble starch in 100 ml of boiling water, boil for 2 minutes, cool and dilute to 150 ml with water. Add solution (1) to half the starch mucilage and solution (2) to the remainder and maintain the mixtures at 38° to 40° for 5 minutes. To 1 ml of each mixture add 10 ml of iodinated potassium iodide solution. The liquid containing solution (2) retains the colour of the solution of iodine and the liquid containing solution (1) acquires an intense blue colour.TESTSFatExtract 1 g with petroleum spirit (boiling range, 40° to 60°) for 3 hours in an apparatus for the continuous extraction of drugs, Appendix XI F, evaporate the extract and dry the residue at 105° for 2 hours. The residue weighs not more than 30 mg.Loss on dryingWhen dried at 60° at a pressure not exceeding 0.7 kPa for 4 hours, loses not more than 5.0% of its weight. Use 0.5 g.Microbial contamination1 g is free from Escherichia coli; 10 g is free from Salmonella, Appendix XVI B1.ASSAYCarry out the assay of pancreatin described below.STORAGEPancreatin should be stored at a temperature not exceeding 15°.LABELLINGThe label states (1) the minimum number of Units of activity of free protease, lipase and amylase per mg; (2) the name of any added substance; (3) the date after which the material is not intended to be used; (4) the conditions under which it should be stored.ASSAY OF PANCREATINThe free protease, lipase and amylase activities of pancreatin are determined by the following methods.STANDARD PREPARATION AND UNITSThe Standard Preparation is the appropriate FIP Standard which has been adopted as an official preparation by the European Pharmacopoeia Commission and is available as pancreas powder (protease) EPBRP or pancreas powder (amylase and lipase) EPBRP as appropriate.The Unit of protease activity is contained in that amount of the Standard Preparation that, under the conditions of the assay, hydrolyses casein at an initial rate such that there is liberated per minute an amount of peptides not precipitated by trichloroacetic acid that gives the same absorbance at 275 nm as one micromole of tyrosine. The Unit of lipase activity is contained in that amount of the Standard Preparation that, under the conditions of the assay, liberates one micro-equivalent of acid per minute at pH 9.0 and 37°. The Unit of amylase activity is contained in that amount of the standard preparation that, under the conditions of the assay, decomposes starch at an initial rate such that one micro-equivalent of glycosidic linkage is hydrolysed per minute.FOR FREE PROTEASE ACTIVITYMethodSolution of the standard preparation Triturate for 5 minutes a quantity of the Standard Preparation containing approximately 100 Units of protease activity with 25 ml of calciumchloride solution cooled to 5°. Dilute to 100 ml with the cooled calcium chloride solution and then dilute a sufficient quantity of the resulting suspension to 100 ml with borate buffer pH 7.5, cooled to 5°, so that 1 ml of the final solution contains 0.065 Units of protease activity. Solution of the substance being examined Triturate for 5 minutes a quantity of the substance being examined containing approximately 100 Units of protease activity with 25 ml of calcium chloride solution cooled to 5°. Dilute to 100 ml with the cooled calcium chloride solution and then dilute a sufficient quantity of the resulting suspension to 100 ml with borate buffer pH 7.5, cooled to 5°, so that the estimated free protease activity corresponds approximately to the activity of the solution of the Standard Preparation.Label 16 test tubes with the following identification in duplicate; S1, S2, S3, S1B, S2B, S3B, U and UB. To tubes S1 and S1B add 2.0 ml and to tubes S2, S2B, U and UB, 1.0 ml of borate buffer pH 7.5. Then to tubes S1 and S1B add 1.0 ml, to tubes S2 and S2B, 2.0 ml and to tubes S3 and S3B, 3.0 ml of the solution of the Standard Preparation. Add 2.0 ml of the solution of the substance being examined to tubes U and UB. To each of the control tubes (S1B, S2B,S3B and UB) add 5.0 ml of a 5% w/v solution of trichloroacetic acid and mix. Place a stirring rod in each tube and warm to, and maintain at, 35° in a water bath. Add 5.0 ml of concentrated casein substrate to each of the control tubes and mix.At accurately timed intervals add 5.0 ml of concentrated casein substrate, previously warmed to 35°, to tubes S1, S2, S3 and U and mix immediately. After exactly 30 minutes, in the same order, stop the reaction in tubes S1, S2, S3 and U by adding 5.0 ml of a 5% w/v solution of trichloroacetic acid and mix thoroughly. Remove all the test tubes from the water bath and allow to stand at room temperature for 20 minutes. Filter the contents of the tubes through suitable filter paper1 , collect the filtrates and refilter through the same paper. The filtrates must be free from haze.Measure the absorbances of the filtrates at the maximum at 275 nm, Appendix II B, using in the reference cell a mixture of 6.0 ml of borate buffer pH 7.5 and 5.0 ml of the 5% w/v solution of trichloroacetic acid that has been filtered in the same way. Correct the mean absorbances of the filtrates from tubes S1, S2 and S3 by subtracting the mean absorbances of the filtrates from the corresponding control tubes S1B, S2B and S3B.Prepare a reference curve by plotting the mean corrected absorbances against the potency of the dilution of the solution of the Standard Preparation used. Calculate the corrected mean absorbance of the substance being examined by subtracting the mean absorbance of the filtrates from tubes UB from that of the filtrates from tubes U. Using the corrected mean absorbance, determine the potency of the solution of the substance being examined from the reference curve and calculate the free protease activity per mg of the substance being examined by taking into account the dilution factors.The test is not valid unless the corrected absorbances are between 0.15 and 0.60.FOR LIPASE ACTIVITYApparatusUse a reaction vessel of about 50 ml capacity fitted with a device that will maintain a temperature of 36.5° to 37.5°, a magnetic stirrer and a lid with holes for the insertion of electrodes, the tip of a burette, a tube for the admission of nitrogen and the introduction of reagents. An automatic or manual titration apparatus may be used. In the latter case, the burette is graduated in 5-µl divisions and the pH meter is provided with a wide reading scale and glass and calomel electrodes. After each test the reaction vessel is evacuated by suction and washed several times with water, the washings being removed each time by suction. MethodCarry out the assay under nitrogen. In a small mortar cooled to 0° to 4° triturate carefully an amount of the substance being examined containing approximately 2500 Units of lipase activity with 1 ml of cooled lipase solvent until a very fine suspension is obtained (about 10 minutes). Dilute with cooled lipase solvent, transfer quantitatively to a graduated flask and dilute to 100.0 ml with the cooled solvent; use immediately.Transfer 29.5 ml of olive oil substrate emulsion to the assembled reaction vessel equilibrated at 36.5° to 37.5° and adjust the pH to 9.2 with 0.1M sodium hydroxide. Add about 0.5 ml of the suspension of the substance being examined and record the time at which the pH reaches 9.0. Add continuously from a micrometer syringe sufficient 0.1M sodium hydroxide VS to maintain the pH at 9.0. Record the volume of 0.1M sodium hydroxide VS consumed at 1-minute intervals for 5 minutes. Discounting the first reading, calculate the mean rate of alkali consumption U. If necessary, dilute with sufficient lipase solvent to produce an average alkali consumption of 0.08 to 0.16 ml of 0.1M sodium hydroxide VS per minute. Repeat the procedure using the Standard Preparation in place of the substance being examined and calculate the mean rate of alkali consumption, S. Calculate the potency (P L) of the substance being examined in Units per mg from the expression:Where U=the mean volume in ml of 0.1M sodium hydroxide VS used perminute in the titration of the substance being examined, S=the mean volume in ml of 0.1M sodium hydroxide VS used perminute in the titration of the Standard Preparation,w=weight in mg of the substance being examined,w s=weight in mg of the Standard Preparation,R=potency of the Standard Preparation in Units per mg.Calculate the potency of the substance being examined using the average of three separate titrations for both the substance being examined and the Standard Preparation.FOR AMYLASE ACTIVITYMethodTriturate an amount of the substance being examined containing approximately 1500 Units of amylase activity with 60 ml of 0.2M mixed phosphate buffer pH 6.8 for 15 minutes and add sufficient 0.2M mixed phosphate buffer mixed phosphate buffer p H 6.8 to produce 100 ml. To a stoppered tube (200 mm × 22 mm) add 25.0 ml of starch substrate, 10.0 ml of 0.2M mixed phosphate buffer pH 6.8 and 1.0 ml of 0.2M sodium chloride. Stopper the tube, mix the contents and place in a water bath at 24.9° to 25.1°. When the temperature of the mixture has reached 25° add 1.0 ml of the solution of the substance being examined and record the time of addition. Mix thoroughly and replace in the water bath. After exactly 10 minutes add 2 ml of 1M hydrochloric acid to stop the reaction. Transfer the contents of the tube to a stoppered 300 ml flask. While shaking continuously add 10.0 ml of 0.05M iodine VS followedimmediately by 45 ml of 0.1M sodium hydroxide. Allow to stand in the dark at a temperature of 15° to 25° for 15 minutes. Add 4 ml of a mixture of 1 volume of sulphuric acid and 4 volumes of water and titrate with 0.1M sodium thiosulphate VS. Repeat the procedure but add the 2 ml of 1M hydrochloric acid before the addition of the solution of the substance being examined. Prepare a solution of the Standard Preparation in the same manner as described for the solution of the substance being examined and repeat the procedure beginning at the words 'To a stoppered tube …' but using 1.0 ml of this solution in place of the solution of the substance being examined.Calculate the potency (P A) of the substance being examined in Units per mg from the expression:Where A=volume in ml of 0.1M sodium thiosulphate VS used in thetitration of the substance being examined,A s=volume in ml of 0.1M sodium thiosulphate VS used in thetitration of the Standard PreparationB=volume in ml of 0.1M sodium thiosulphate VS used in thetitration of the substance being examined inactivated by theaddition of 1M hydrochloric acid,B s=volume in ml of 0.1M sodium thiosulphate VS used in thetitration of the Standard Preparation inactivated by theaddition of 1M hydrochloric acid,Q=potency of the Standard Preparation in Units per mgw=total weight in mg of the substance being examined in thesolution prepared for assay,w s=total weight in mg of the Standard Preparation in the solutionprepared for assay.1A suitable filter paper complies with the following test. Filter 5 ml of a 5% w/v solution of。

药物用法拉丁文缩写词拉丁文缩写

一、药物用法拉丁文缩写词拉丁文缩写中文意义ac 饭前pc 饭后am 上午pm 下午sos 需要时，限用一次prn 必要时，长期备用医嘱st 立即，急速pN 每晚hs 睡前Qd 每日一次Bid 每日二次Tid 每日三次Qid 每日四次Q6h 每6小时一次12mn 中午12小时12n 24小时二,医嘱常用拉丁文缩写词拉丁文缩写中文意义aa 各po 口服ad us,int 内服ad us,ext 外用sig 用法,指示NPO 禁食Di 停用Rp 取ss 一半Ad 加至ps 适量Dil 稀释et 及,和MDS 混合后给予co;comp 复方的No;N 数目,个lnj 注射剂Tab 片剂pil 丸剂caps 腋囊剂Amp 安瓿剂Mist 合剂Emul 乳剂Syr 糖浆剂Tr 酊剂Neb 喷雾剂Garg 含漱剂Gtt;gutt 滴,滴眼剂collyr 洗眼剂Ocal 眼膏Liq 溶液剂Sol 溶液Lot 洗剂Linim 擦剂Crem 乳膏剂Ung 软膏剂past 糊剂Ol 油剂Enern 灌肠剂Supp 栓剂iH 皮下注射im 肌肉注射iv 静脉注射iv.gtt,iv.drip 静脉滴注sc，结膜下注射Sig 用法、指示qm 每晨1次qn 每晚1次hs 睡前ac 饭前pc 饭后st 立即sos 需要时prn 必要时po 口服ID 皮内注射H 皮下注射IM 肌肉注射IV 静脉注射iv.gtt iv.drip 静脉滴注5％G.S 5％的葡萄糖N.S 生理盐水G.N 葡萄糖盐水qd 每日一次bid 每日两次tid 每日三次qid 每日四次qh 每小时一次q2h 每两小时一次q4h 每四小时一次q6h 每六小时一次qn 每晚一次qod 隔日一次biw 每周两次hs 临睡前am 上午pm 下午St 立即DC 停止prn 需要时（长期）sos 需要时（限用一次，12小时内有效） 12n 中午12点 12mn午夜12点i.m. Injectio musculosa 肌肉注射 i.v. Injectio venosa 静脉注射 Lin. Inimentum 擦剂Liq. Liquor,liquidus 溶液，液体的 Lit. Litrum 升 Lot Lotio 洗剂 Mist. Mistura 合剂 Ml. Millilitrum 毫升 Mg. Milligramma 毫克 Muc. Mucilago 胶浆剂 N Nocte 夜晚n.et.m Nocte et mane 在早晚 Neb. Nebula 喷雾剂 o.d. Omni die 每日O.D. Oculus dexter 右眼 O.L. Oculus laevus 左眼 O.S. Oculus sinister 左眼 O.U. Oculi utrigue 双眼 Ol. Oleum 油Om.bid. Omni biduo 每2日 Om.d.(o.d.) Omni die 每日Om.hor.(o.h.) Omni hora 每小时 Om.man. Omni mane 每日早晨 Om.noc.(o.n.)Omni nocte 每日晚上 p.c. Post cibos 饭后 p.o. Per os 口服 Pil. Pilula 丸剂p.j. Post jentaculum 早饭后 p.m. Post meridiem 午后p.prand. Post prandium 午饭后 Pcoen. Post coenam 晚饭后 Pro us.ext Pro usu externo 外用.int. Pro usu interno 内用，内服 Pro us.med. Pro usu medicinali 药用 Pro us.vet. Prousu veterinario 兽医用 Pulv. Pulvis 粉剂、散剂 Pt. Partes 部分p.r.n. Pro kre nata 必要时 q.d. Quaque die 每日q.i.d. Quarter in die 每日4次 q.h. Quaque hora 每1小时 q.4.h. Quaque 4 hora 每4小时 q.l. Quantum libet 任意量 q.n. Quante nocte 每日晚上q.s. Quantum sufficit 足够量 Quantum satis 足够量，适量q.semih. Quaque semihora 每半小时 r.;rad Radix 根 Rec Recens 新鲜的 Rp. Recipe 取Rhiz. Rhizoma 根茎s.;sig. Signa,signetur 标记，指示 s.i.d Semel in die 每日1次 s.l Saccharum lactis 乳糖 s.o.s Si opus(est)sit 需要时 Sem. Semen 种子Ser.;syr. Sirupu,ssyrupus 糖浆 Solut. Solutio 溶液Semih. Semihora 半小时 Sp. Spiritus 醵剂Stat.;st Statim 立刻，立即 Supp. Suppositouium 栓剂 t.i.d. Ter in die 每日3次 t.;tr. Tinctura 酊剂Troch. Trochscus 锭剂，糖锭 Tab. Tabella 片剂 Us. Usus 应用，用途 Ug.;ung. Unguentum 软膏 Us.ext. Usus externus 外用 Us.int. Usus internus 内服 Ut dict Ut dictum 依照嘱咐 Vesp. Vespere 晚上处方上左上角的RP代表“请取”的意思，如果某种药后面是qd、bid、tid,分别代表每日一次、每日两次、每日三次。

抗生素中英文对照表

力派
多
肽
类
万古霉素类
万古霉素
vancomycin
VA,VAN
替考拉宁
teicoplanin
TEC,TPN,TEI,T
P, TPL
多粘菌素类
多粘菌素B、
多粘菌素E
polymyxinB(E)
PB(PE)
氯霉素类
氯霉素
chloramphenicol
C,DHL,CL
磷霉素类
磷霉素
fosfomycin
FOS,FF,FO,FM
分类
化学名
英文全称
英文缩写
商品名
氨
基
糖
苷
类
阿米卡星
amikacin
AN,AK,AMI,AMK
庆大霉素
gentamicin
GM,CN,GEN
链霉素
straptomycin
S,STR,Sts,SM
妥布霉素
tobramycin
NN,TM,TO,TOB
卡那霉素
kanamycin
K,KAN,HLK,KM
奈替米星
CPD,POD,PX
第四代头孢菌素
头孢匹罗
cefpirome
头孢吡肟
cefepime
FEP,Cpe,PM,CPM
马斯平
青霉烯类
亚胺培南
imipenem
IPM,IMI,Imp,IP
泰能
美罗培南
meropenem
MEC
美平倍能
法罗培南
faropenem
FAR,FARO
单环内酰胺类
氨曲南
aztreonam
CE,KF
头孢匹林
cephapirin

药剂词汇英汉对照

药剂词汇英汉对照AAbsolute bioavailability 绝对生物利用度Absorption 吸收Acacia 阿拉伯胶Accelerated stability 加速稳定性实验Accumulation factor蓄积因子Additive 附加剂Adjuvant 辅料Administration 给药，用法Aerosil 微粉硅胶Aerosol 气雾剂Agar 琼胶Aggregation 聚集Albumin 白蛋白Alginate(alginate acid)海藻酸盐（海藻酸）Amorphous form 无定型Amphiphilic 两亲性的Angle of repose 休止角Angle of friction 摩擦角Ampoule 安瓿Anion exchange resin 阴离子交换树脂Antiseptics 防腐剂；消毒剂Antioxidant 抗氧化剂Apparent first-order absorption(elimination)表观一级吸收（消除）Apparent volume of distribution 表观分布容积Rate constant速度，速率Aromatic waters 芳香水剂Aseptic manipulation 无菌操作Autoclave 高压灭菌器Autoxidation 自动氧化Azone 氮酮BBentonite 硅皂土Binder 粘合剂Bioadhesive tablets 生物粘附片Biocompatibility 生物相容性Bioequivalence 生物等效性Biologic half-life 生物半衰期Biotransformation 生物转化Buccal tablets 口含片Buccal administration 颊给药Bulk density 堆密度CCapacity—limited and nonlinear process 能力有限和非线性过程Capillary action 毛细管作用Capping 顶裂Carboxypolymethylene 聚羧乙烯Capsul 胶囊Carnauba wax 巴西棕榈蜡Carbopol 卡波普Carrier-mediated transfer system 载体转运系统Cation exchange resin 阳离子交换树脂Cellulose acetate phthalate(CAP) 邻苯二甲酸醋酸纤维素Cetyl alcohol 鲸蜡醇Chelating agent 螯合剂Chewable tablets 咀嚼片Chipping 裂片Chitin 壳聚糖Chitosan 脱乙酰壳聚糖Chronopharmacokinetics 时辰药物动力学Clarity(test) 澄明度（检查）Cloud point 浊点Co-solvency 潜溶Coagulation 聚沉Coating 包衣Cocoa butter 可可豆脂Cohesiveness 粘着性Colloid mill 胶体磨Comminution 粉碎Comples coacervation method 复凝聚法Content uniformity test 含量均匀试验Controlled release preparation 控释制剂Coprecipitate 共沉淀物Coulter counter 库氏计数器Cracking 松片Creaming 乳析Creatinine clearance 肌酐清除率Critical micelle concentration(cmc) 临界胶束浓度Croscarmellose sodium(ccna)交联羧甲基纤维素钠Crospovidone 交联聚维酮Cyclodextrin inclusion compound 环糊精包合物DDecoction 煎煮法,汤剂Deflocculating agent 反絮凝剂Delayed release 延缓释放Dextrin 糊精Die 模圈，冲磨Differential scanning calorimetry(DSC) 差示扫描量热法Differential thermal analysis(DTA) 差示热分析法Diffusion coefficient 扩散系数Diluents 稀释剂Dimethyl acetamide(DMA) 二甲基乙酰胺Dimethyl formamide(DMF) 二甲基乙酰胺Dimethyl sulfoxide(DMSO) 二甲基亚砜Disinfectant 消毒剂，灭菌剂Disintegrant 崩解剂Dispersible tablets 分散片Displacement value 置换价Dissolution 溶出Distribution 分布Dosage form 剂型Dosage regimen 给药方案Dosing interval 给药间隔Drug compatibility 药物配伍Drug delivery system 药物传递系统Drug disposition 药物处置Duration 作用持续性Dustibility 松散性EEffervescent tablets 泡腾片Elimination 消除Elixirs酏剂Emulsions 乳剂Emulsification 乳化作用Encapsulation coefficency 包封率Endocytosis内吞作用Enemas 灌肠剂Enteric coated tablets 肠衣片Enterohepatic cycle肝肠循环Equivalent diameter 等价径，当量直径Drodible matrix 溶蚀型骨架Ethylene-vinyl acetate copolymer（EVAC）乙烯-醋酸乙烯共聚物Ethyl cellulose（EC）乙基纤维素Eudragit 丙烯酸树脂Eutectic mixture 低共熔混合物Excipient 赋形剂，辅料Extended release持续释放Extract preparation 浸出制剂Extracts 浸膏剂Extravascular administration 血管外给药FFacilitated diffusion 促进扩散Fast 禁食Feed shoe 饲粉靴Fillers 填充剂Film coated tablets 薄膜衣片Filter candle(disk) 滤棒First pass effect 首过效应Flavoring agent 矫味剂Flocculant 絮凝剂Fluctuation 波动性Fluid bed coating(granulation) 流化床包衣制粒Fluid energy mill 流能磨Fluid extracts 流浸膏剂Fluid mosaic model 液体相嵌模型Food and drug adiministration(FDA)食品药品管理局Fomulation 处方Friability 脆碎度Fusion 融合作用GGargles 漱口剂Gelatin 明胶Gelatin glycerin 甘油明胶Gildants 助流剂Glomerular filtration 肾小球滤过Glycerite 甘油剂Glyceryl monostearate 单硬脂酸甘油酯Glycoprotein 蛋白糖Good manufacturing practice(GMP)药品生产质量管理规范Granule density 粒密度Greasing bases 油脂性基质Guest molecule 客分子HHealthy volunteer 健康受试者High-efficiency particle air filter 高效空气过滤嚣Horizontal laminar flow 水平层流Hopper 加料斗Host molecule主分子Hydrocarbon base烃类基质Hydrogel matrix水凝胶骨架Hydrogenated vegetable oil氢化植物油Hydrophile-lipophile balance(HLB)亲水亲油平衡值Hydrophilic metrix亲水性骨架Hydroscopicity吸湿性Hydrotropic agent助溶剂Hydroxypropylmethyl cellulose(HPMC)羟丙基甲基纤维素Hydroxypropylstarch羟丙基淀粉IImplant植入剂In vitro体外In vivo体内Inclusion compound包合物Imcompatibility配合物Imdustrial pharmacy工业药剂学Infusion浸渍，浸剂，输注Inhalation aerosols吸入气雾剂Injection注射剂Instantraneous rate瞬时速率Interfacial polymerization界面缩聚法Intra uterine device(IUD)宫内给药嚣Intra vaginal ring(IVR)阴道环Intravenous infusion静脉滴注Inulin菊粉Iontophoresis离子等渗Irrigations灌洗剂Iso-osmotic solution等渗溶液Isotonic solution等张溶液Isotonicity等张性JThe Parmacopoeia of japan日本药局方KKidney function肾功能Kinetics parameter动力学参数LL-hydroxypropyl cellulose(L-HPC)低取代羟丙基纤维素Lactose乳糖Lag time时滞Lake色淀Laminar flow clean bench层流洁净工作台Lamination层裂Leak test(testing)漏气试验Lecithin(e)卵磷脂Linuis test鲎试验Liniment涂抹油，擦剂Liposome脂质体Loading dose负荷剂量Lotion洗剂Lubricants润滑剂Lyophilic亲液的Lyophilization冷冻干燥Lyophobic疏液的MMaceration浸渍Macromolecular solution高分子溶液Macrovesicle liposome大多孔脂质体Magnetic microspheres磁性微球Maintenance dose维持剂量Matrix tablets骨架片Mean residence time(MRT)平均滞留时间Medicinal liquor洒剂Membrane evaporator薄膜浓缩器Metastable亚稳的Methyl cellulose(MC)甲基纤维素Micelle胶团Michaelis-menten kinetics MM动力学Microcapsules微囊Microspheres 微球Microcrystalline cellulose微晶纤维素Microemulsion微乳Microencapsulation微型包囊技术Micronise微粉化Microporous membrane微孔膜Microvilli微绒毛Migration迁移Minimun effective concentration(level)最小有效浓度Minimun toxic concentration最小中毒浓度Mixer混合机Mixtures合剂Moistening agent润湿剂Monoclonal antibody单克隆抗体Mottling色斑Mucilages胶浆剂Multilamellar,multiple compartment liposome多室脂质体Multiple compartment model多室脂质体Multiple dosing多剂量给药Multiple emulsion复合型乳剂NNanocapsule毫微胶囊Nanoparticles毫微粒Nanospheres毫微球Naris drops滴鼻剂Nasal administration鼻腔给药Nonlinear pharmacokinetics非线性药物动力学National formulary美国药局方Nipagin(parabens)尼泊金OOintment软膏剂Oleaginous base油性基质One compartment model单室模型Onset起效时间Ophthalmic preparation眼用制剂Optimization technique优化技术Oral administration口服给药Oral osmotic pump口服渗透泵PParaffin石蜡Partition coefficient分配系数Passive diffusion被动扩散Passive target preparation被动靶向制剂Pastes 糊剂Peeling剥落Pellet小丸Penetration enhancer穿透促进剂Percolation渗漉Percutaneous administration经皮给药Permeability coefficient穿透系数Perogol O平平加OPH-partition theory PH-分配学说Pharmaceutics药剂学Pharmacokinetics药物动力学Pharmacopoeia药典Pharmacy药学Phase separation-coacervation相分享凝聚法Phase transition temperature相变温度Picking粘连Pill丸剂Plaster硬膏剂Plastic flow塑性流动plasticizer增塑剂Plateau concentration(level)坪浓度Pluronic F-68普朗尼克F-68Polishing,smoothing打光Poloxamer泊洛沙姆Polyacrylamide聚丙烯酰胺Polyacrylic acid聚丙烯酸Polyethylene glycols(PEC)聚乳酸Polymerization聚合Polymorphism多晶型Polymethyl methacrylate聚甲基丙烯酸甲酯Polyvinyl alcohol(PVA)聚乙烯醇Polyvinylpyrrolidone(PVP)(povidone)聚维酮Porosity孔隙率Powders散剂Preformulation处方前工作Preagelatinized starch预胶化淀粉Prescription处方Preservative防腐的Prodrug前体药物Propellants抛射剂Pseudo plastic flow伪一级反应Pulsed and regulated drug deliver system伪塑性流动Pulverization脉冲式和自调式释药系统Punch粉碎Pyrogen冲头RRate method 冲率法Rate-limiting step限速步骤Rectal dosage form直肠给药剂型Relative bioavailability相对生物利用度Residuals method殘数法Rheology流动学SSedimentation沉降Semipermeable membrane半透膜Shellac虫胶Sieve筛（子），筛（分）Sigma-minus method 总量减去法Silicone硅酮Simple coacervation method单凝聚法Single-punch press单冲压片机Sintered glass filter垂熔玻璃滤品Sodium carboxyl methyl cellulose (CMC-Na)羧甲基纤维素钠Sodium carboxyl methyl starch(CMS-Na)羧甲基淀粉纳Sodium lauryl sulfate十二烷基硫酸钠Solid dispersion固体分散体Solidification固化Solubilization增溶作用Solvate溶剂化物Sonication dispersion method超声分散法Spans司盘类Specific acid-base catalysis特殊酸碱催化Specification规格，说明书Spermacete wax鲸蜡Spirits醑剂Spray喷雾剂Stability稳定性Starch淀粉Statistical moment统计矩Steady-state稳态Stearyl alcohol十八醇Sterilization灭菌Sterilizer消毒器Sticking粘冲Sublingual tablet舌下片Sugar coated tablet糖衣片Superdisintegrants超级崩解剂Suppositories栓剂Surfactant表面活性剂Suspending agent助悬剂Suspensions混悬剂Sustained release preparation缓释制剂Sweeting agent甜味剂Syrups 糖浆剂Systemic clearance总清除率TTablets片剂Talc滑石粉Targeted drug delivery system(TDDS)靶向给药系统Terylene涤纶薄膜The area under the plasma concentration-time curve血浓时间曲线下面积The extra pharmacopoeia药学大全The international pharmacopoeia国际药典The membrane of epithelial cell上皮细胞膜The rate of gastric emptying胃排空速率Theobrome oil可可豆油Therapeutic concentration range治疗浓度范围Therapeutic equivalence治疗等效性Thixotropy触变性Time course经时过程Tincture酊剂Tragacanth西黄芪胶Transdermal therapeutic system(TTS)透皮治疗系统Transport转运Trapezoidal rule 梯形法则True density真密度Tubular reabsorption肾小管重吸收Tubular secretion肾小管分泌Tweens吐温类UUntrafiltration超滤Unilamellar,single compartment liposome单室脂质体Urinary excretion尿排泄The pharmacopeia of united states(usp)美国药典VVaseline(e)凡士林Vertical laminar flow垂直层流WWater for injection注射用水Wettability可湿性Wetting agent润湿剂ZZein 玉米朊--。

药物分析专业词汇中英文对照

药物分析专业词汇中英文对照绪论释药系统（drug delivery system，DDS）中国药典（Chinese Pharmacopoeia,ChP）美国药典（The United States Pharmacopoeia,USP）美国国家处方集（The National Formulary,NF）英国药典（British Pharmacopoeia,BP）欧洲药典（European Pharmacopoeia,Ph.Eup）国际药典（The International Pharmacopoeia,Ph.Int）良好药品实验研究规范（Good Laboratory Practice,GLP）良好药品生产规范(Good Manufacture Practice,GMP)良好药品供应规范(Good Supply Practice,GSP)良好药品临床试验规范(Good Clinical Practice,GCP)分析质量管理(Analytical Quality Control,AQC)第1章药物的鉴别试验药物的鉴别试验identification test一般鉴别试验general identification test专属鉴别试验specific identification test灵敏度sensitivity最低检出量minimum detectable quantity最低检出浓度minimum detectable concentration第2章药物的杂质检查巯基醋酸mercaptoacetic acid古蔡氏Gutzeit二乙基二硫代氨基甲酸银siliver diethyldithio-carbamate硫酸灰分sulphated ash炽灼残渣residue on ignition热重分析法thermogravimetric analysis,TGA差示热分析法differential thermal analysis,DTA差示扫描量热法differential scanning calorimetry,DSC碱性酒石酸铜试验Fehling’s reagent异红紫酸盐isopurpurate2，3-二氨基萘2,3-diaminonaphthalene4，5-苯并苯硒二唑4，5-benzopiazselenol第3章定量分析样品前处理与测定方法的效能指标汞齐化法amalgamation method氧瓶燃烧法oxygen flask combustion method葡萄糖醛酸甙glucuronides硫酸酯sulphates血浆plasma血清serum全血whole blood治疗药物浓度监测therapeutic drug monitoring,TDM结合bound游离free缀合物conjugate l液-液提取法liquid-liquid extraction,LLE离子对试剂ion pair reagent离子对提取法ion pair extraction method反离子counter液-固提取法liquid-solid extraction LSE半自动样品制备系统advanced automated sample processor,AASP 烷基化alkylations酰基化acylations L硅烷化silylations精密度precision标准差standard deviation,SD orS相对标准差relative standard deviation变异系数coefficient of variation,批内精密度within-run precision日内精密度within-day precision批间精密度between-run precision日间精密度day to day precision准确度accuracy定量限limit of quantitation,LOQ检测限limit of detection,LOD选择性selectivity专属性specificity线性与范围linearity and range重现性ruggedness耐用性robustness散布图scatter diagram+y r:L!z7\9^'T3l'h*M荧光偏振免疫测定法fluorescence polarization immunoassay第4章巴比妥类药物的分析溴化十六烷基三甲基苄铵cetyltrimethylbenzylammonium bromide，CTMA 氯化四癸基二甲基苄铵T etradacyldimethybenzylammonium chloride，TDBA第5章芳酸及其酯类药物的分析苯甲酸及其钠盐benzoic acid and sodium benzoate布美他尼bumetanide羟苯乙酯ethylparoben丙磺舒probenecid酚黄乙胺etamsylate第6章胺类药物的分析第7章杂环类药物的分析二硝基氯苯反应Vongerichten反应戊烯二醛反应反应第8章生物碱类药物的分析生物碱alkaloids阿片gum opium扫尾剂tailing-suppressing reagent蒂巴因thebaine诺司卡品noscapine竞争离子competing ions亲脂性lipophicity拖尾因子tailing factor金刚烷adamantane第9章维生素类药物的分析维生素vitamin去氢维生素A dehydroretinol去水维生素A anhydroretinol鲸醇kitol三氯化锑反应Carr-Price反应维生素B1 thiamine hydrochloride；盐酸硫胺2，3，5-三苯基氯化四氮唑2，3，5-triphenyltetrazolium chlorid，TTC红四氮唑red tetrazoline，RT蓝四氮唑blue tetrazoline，BT3，3’-二甲基氧苯基-双-4，4’-（3，5-二苯基）氯化四氮唑{3，3’-dianisole-bis[4，4’-（3，5-dipheny）tetrazolium chloride]}有色甲……formazan铁-酚试剂iron-phenol reagente铁-柯柏试剂iron-Kober reagent南药07药理复试题一、名词解释（5分*10）1、一级动力学消除；2、非竞争性拮抗剂；3、动作电位时程；4、前致癌物；5、初次接触效应；6、synergism；7、mutation；8、GLP；9、acute toxicity；10、uptake1。

英国药典Appendix XVI C翻译

部分常用药物中英文名称对照表

中国药典附录Ⅰ(A-Z)中英文对照

英国药典 二氧化硅含量标准-概述说明以及解释

英国药典2012 有关物质项译文

药物用法拉丁文缩写词 拉丁文缩写

药物分析常用英语词汇

药物缩写,别名,处方缩写整理

药物拉丁文缩写

bronopol- 英国药典09

常用药品拉丁文

处方常用拉丁文缩写

英国药典Appendix XVI C翻译

胰酶-英国药典s2009

药物用法拉丁文缩写词拉丁文缩写

抗生素中英文对照表

药剂词汇英汉对照

药物分析 专业词汇中英文对照

英国药典二氧化硅含量标准-概述说明以及解释

药物用法拉丁文缩写词拉丁文缩写

药物分析专业词汇中英文对照